Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma

Abstract Temporalis muscle thickness (TMT) on brain magnetic resonance imaging (MRI) is correlated with sarcopenia and can be a predictive marker for survival in patients with brain tumors, but the association of TMT on head and neck computed tomography (CT) with survival in head and neck squamous c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Boeun Lee, Yun Jung Bae, Woo-Jin Jeong, Hyojin Kim, Byung Se Choi, Jae Hyoung Kim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/358c51d1413248beb31f5564c2eddf15
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:358c51d1413248beb31f5564c2eddf15
record_format dspace
spelling oai:doaj.org-article:358c51d1413248beb31f5564c2eddf152021-12-02T17:13:16ZTemporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma10.1038/s41598-021-99201-32045-2322https://doaj.org/article/358c51d1413248beb31f5564c2eddf152021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99201-3https://doaj.org/toc/2045-2322Abstract Temporalis muscle thickness (TMT) on brain magnetic resonance imaging (MRI) is correlated with sarcopenia and can be a predictive marker for survival in patients with brain tumors, but the association of TMT on head and neck computed tomography (CT) with survival in head and neck squamous cell carcinoma (HNSCC) remains unclear. We investigated whether TMT on CT could predict progression-free survival (PFS) in patients with HNSCC. A total of 106 patients with newly diagnosed HNSCC were included in this retrospective study. The patients underwent baseline head and neck CT and/or MRI between July, 2008 and August, 2018. The correlation between TMT on CT and MRI was tested using intraclass correlation coefficient (ICC). The cut-off value of TMT on CT for determining tumor progression was identified using receiver-operating characteristic curve analysis. Uni- and consecutive multi-variable Cox regression models were used to verify the association between TMT and PFS. TMT on CT and MRI showed excellent correlation (ICC, 0.894). After a mean follow-up of 37 months, 49 out of 106 patients showed locoregional recurrence and/or distant metastasis. The cut-off TMT of 6.47 mm showed good performance in predicting tumor progression (area under the curve, 0.779). The Cox regression model showed that TMT ≤ 6.24 mm (median value in study population) was a significant contributing factor for predicting shorter PFS (hazard ratio 0.399; 95% confidence interval 0.209–0.763; P = .005). TMT may be used as a surrogate parameter for pre-treatment sarcopenia and could help predict PFS in patients with HNSCC.Boeun LeeYun Jung BaeWoo-Jin JeongHyojin KimByung Se ChoiJae Hyoung KimNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Boeun Lee
Yun Jung Bae
Woo-Jin Jeong
Hyojin Kim
Byung Se Choi
Jae Hyoung Kim
Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma
description Abstract Temporalis muscle thickness (TMT) on brain magnetic resonance imaging (MRI) is correlated with sarcopenia and can be a predictive marker for survival in patients with brain tumors, but the association of TMT on head and neck computed tomography (CT) with survival in head and neck squamous cell carcinoma (HNSCC) remains unclear. We investigated whether TMT on CT could predict progression-free survival (PFS) in patients with HNSCC. A total of 106 patients with newly diagnosed HNSCC were included in this retrospective study. The patients underwent baseline head and neck CT and/or MRI between July, 2008 and August, 2018. The correlation between TMT on CT and MRI was tested using intraclass correlation coefficient (ICC). The cut-off value of TMT on CT for determining tumor progression was identified using receiver-operating characteristic curve analysis. Uni- and consecutive multi-variable Cox regression models were used to verify the association between TMT and PFS. TMT on CT and MRI showed excellent correlation (ICC, 0.894). After a mean follow-up of 37 months, 49 out of 106 patients showed locoregional recurrence and/or distant metastasis. The cut-off TMT of 6.47 mm showed good performance in predicting tumor progression (area under the curve, 0.779). The Cox regression model showed that TMT ≤ 6.24 mm (median value in study population) was a significant contributing factor for predicting shorter PFS (hazard ratio 0.399; 95% confidence interval 0.209–0.763; P = .005). TMT may be used as a surrogate parameter for pre-treatment sarcopenia and could help predict PFS in patients with HNSCC.
format article
author Boeun Lee
Yun Jung Bae
Woo-Jin Jeong
Hyojin Kim
Byung Se Choi
Jae Hyoung Kim
author_facet Boeun Lee
Yun Jung Bae
Woo-Jin Jeong
Hyojin Kim
Byung Se Choi
Jae Hyoung Kim
author_sort Boeun Lee
title Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma
title_short Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma
title_full Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma
title_fullStr Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma
title_full_unstemmed Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma
title_sort temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/358c51d1413248beb31f5564c2eddf15
work_keys_str_mv AT boeunlee temporalismusclethicknessasanindicatorofsarcopeniapredictsprogressionfreesurvivalinheadandnecksquamouscellcarcinoma
AT yunjungbae temporalismusclethicknessasanindicatorofsarcopeniapredictsprogressionfreesurvivalinheadandnecksquamouscellcarcinoma
AT woojinjeong temporalismusclethicknessasanindicatorofsarcopeniapredictsprogressionfreesurvivalinheadandnecksquamouscellcarcinoma
AT hyojinkim temporalismusclethicknessasanindicatorofsarcopeniapredictsprogressionfreesurvivalinheadandnecksquamouscellcarcinoma
AT byungsechoi temporalismusclethicknessasanindicatorofsarcopeniapredictsprogressionfreesurvivalinheadandnecksquamouscellcarcinoma
AT jaehyoungkim temporalismusclethicknessasanindicatorofsarcopeniapredictsprogressionfreesurvivalinheadandnecksquamouscellcarcinoma
_version_ 1718381370030424064